Financial Snapshot

Revenue
$49.13B
TTM
Gross Margin
82.22%
TTM
Net Earnings
$6.440B
TTM
Current Assets
$25.39B
Q2 2024
Current Liabilities
$28.57B
Q2 2024
Current Ratio
88.89%
Q2 2024
Total Assets
$104.3B
Q2 2024
Total Liabilities
$64.83B
Q2 2024
Book Value
$39.51B
Q2 2024
Cash
$6.916B
Q2 2024
P/E
30.45
Nov 29, 2024 EST
Free Cash Flow
$6.967B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Revenue $45.81B $44.35B $37.42B $26.62B $24.38B $22.09B $22.47B $23.00B $24.71B $26.55B $25.71B $27.97B $33.59B $33.27B $32.80B $31.60B $29.56B $26.48B $23.95B $21.43B $18.85B $17.84B $16.48B $18.10B $18.45B $9.130B $8.511B $8.369B $7.729B $6.857B $6.665B $6.981B $6.925B
YoY Change 3.29% 18.53% 40.58% 9.16% 10.38% -1.67% -2.33% -6.9% -6.93% 3.25% -8.09% -16.72% 0.97% 1.42% 3.81% 6.91% 11.65% 10.54% 11.78% 13.67% 5.65% 8.26% -8.97% -1.85% 102.03% 7.27% 1.7% 8.28% 12.72% 2.88% -4.53% 0.81%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Revenue $45.81B $44.35B $37.42B $26.62B $24.38B $22.09B $22.47B $23.00B $24.71B $26.55B $25.71B $27.97B $33.59B $33.27B $32.80B $31.60B $29.56B $26.48B $23.95B $21.43B $18.85B $17.84B $16.48B $18.10B $18.45B $9.130B $8.511B $8.369B $7.729B $6.857B $6.665B $6.981B $6.925B
Cost Of Revenue $8.053B $8.649B $9.542B $5.270B $4.824B $4.246B $4.180B $4.044B $4.488B $5.589B $5.135B $5.257B $5.972B $6.245B $5.587B $6.193B $6.004B $5.559B $5.356B $5.193B $4.469B $4.520B $4.456B $5.480B $6.000B $3.566B $3.239B $3.511B $3.317B $3.026B $2.830B $2.844B $2.730B
Gross Profit $37.76B $31.96B $27.88B $21.35B $19.56B $17.84B $18.29B $18.96B $20.22B $20.96B $20.58B $22.72B $27.62B $27.02B $27.22B $25.41B $23.56B $20.92B $18.59B $16.23B $14.38B $13.32B $12.02B $12.62B $12.45B $5.564B $5.271B $4.858B $4.412B $3.831B $3.835B $4.137B $4.195B
Gross Profit Margin 82.42% 72.06% 74.5% 80.2% 80.22% 80.78% 81.39% 82.42% 81.84% 78.95% 80.03% 81.21% 82.22% 81.23% 82.97% 80.4% 79.69% 79.0% 77.64% 75.76% 76.29% 74.67% 72.96% 69.73% 67.47% 60.94% 61.93% 58.05% 57.08% 55.87% 57.54% 59.26% 60.58%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Selling, General & Admin $15.74B $18.42B $11.52B $9.338B $8.964B $8.479B $7.650B $8.052B $9.604B $10.54B $9.171B $9.528B $10.87B $10.38B $11.23B $10.73B $10.61B $9.322B $8.906B $8.445B $7.018B $6.139B $5.549B $5.717B $5.913B $2.764B $2.556B $2.448B $2.405B $2.193B $2.156B $2.719B $2.411B
YoY Change -14.57% 59.9% 23.36% 4.17% 5.72% 10.84% -4.99% -16.16% -8.88% 14.93% -3.75% -12.33% 4.74% -7.58% 4.67% 1.07% 13.84% 4.67% 5.46% 20.33% 14.32% 10.63% -2.94% -3.31% 113.93% 8.14% 4.41% 1.79% 9.67% 1.72% -20.71% 12.77%
% of Gross Profit 41.68% 57.63% 41.32% 43.74% 45.83% 47.52% 41.84% 42.47% 47.5% 50.29% 44.57% 41.94% 39.35% 38.4% 41.25% 42.22% 45.05% 44.57% 47.9% 52.02% 48.8% 46.09% 46.15% 45.29% 47.51% 49.68% 48.49% 50.39% 54.51% 57.24% 56.22% 65.72% 57.47%
Research & Development $10.27B $9.762B $8.519B $6.094B $5.320B $5.266B $5.412B $5.664B $5.603B $4.941B $4.269B $4.452B $4.506B $4.093B $4.356B $5.013B $5.162B $3.902B $3.379B $3.467B $3.451B $3.069B $2.687B $2.842B $2.813B $1.173B $1.070B $939.0M $866.0M $793.0M $779.0M $823.0M $663.0M
YoY Change 5.19% 14.59% 39.79% 14.55% 1.03% -2.7% -4.45% 1.09% 13.4% 15.74% -4.11% -1.2% 10.09% -6.04% -13.11% -2.89% 32.29% 15.48% -2.54% 0.46% 12.45% 14.22% -5.45% 1.03% 139.81% 9.63% 13.95% 8.43% 9.21% 1.8% -5.35% 24.13%
% of Gross Profit 27.2% 30.54% 30.56% 28.55% 27.2% 29.51% 29.6% 29.88% 27.71% 23.58% 20.75% 19.6% 16.31% 15.15% 16.0% 19.73% 21.91% 18.66% 18.17% 21.36% 24.0% 23.04% 22.35% 22.51% 22.6% 21.08% 20.3% 19.33% 19.63% 20.7% 20.31% 19.89% 15.8%
Depreciation & Amortization $5.387B $5.480B $6.530B $3.149B $3.762B $3.753B $3.036B $2.357B $2.852B $3.282B $4.583B $2.518B $2.550B $2.741B $2.087B $2.620B $1.856B $1.345B $1.327B $1.268B $1.290B $960.0M $860.0M $988.0M $1.069B $408.0M $354.0M $339.0M $306.0M $271.0M $258.0M
YoY Change -1.7% -16.08% 107.37% -16.29% 0.24% 23.62% 28.81% -17.36% -13.1% -28.39% 82.01% -1.25% -6.97% 31.34% -20.34% 41.16% 37.99% 1.36% 4.65% -1.71% 34.38% 11.63% -12.96% -7.58% 162.01% 15.25% 4.42% 10.78% 12.92% 5.04%
% of Gross Profit 14.27% 17.15% 23.43% 14.75% 19.23% 21.03% 16.6% 12.43% 14.1% 15.66% 22.27% 11.08% 9.23% 10.14% 7.67% 10.31% 7.88% 6.43% 7.14% 7.81% 8.97% 7.21% 7.15% 7.83% 8.59% 7.33% 6.72% 6.98% 6.94% 7.07% 6.73%
Operating Expenses $28.53B $28.18B $22.97B $16.95B $15.77B $15.41B $14.45B $14.86B $14.70B $15.79B $13.78B $13.27B $14.63B $13.82B $15.29B $15.32B $15.25B $12.86B $12.09B $11.69B $10.27B $8.965B $7.868B $8.293B $8.537B $3.746B $3.497B $3.230B $3.104B $2.822B $2.778B $3.543B $3.074B
YoY Change 1.23% 22.67% 35.55% 7.45% 2.36% 6.65% -2.75% 1.07% -6.89% 14.6% 3.81% -9.27% 5.84% -9.63% -0.2% 0.5% 18.54% 6.37% 3.47% 13.8% 14.55% 13.94% -5.12% -2.86% 127.9% 7.12% 8.27% 4.06% 9.99% 1.58% -21.59% 15.26%
Operating Profit $9.231B $3.779B $4.902B $4.399B $3.787B $2.434B $3.836B $4.100B $5.520B $5.170B $6.799B $9.445B $12.99B $13.20B $11.93B $10.09B $8.309B $8.054B $6.502B $4.547B $4.111B $4.356B $4.156B $4.330B $3.908B $1.818B $1.774B $1.628B $1.308B $1.009B $1.057B $594.0M $1.121B
YoY Change 144.27% -22.91% 11.43% 16.16% 55.59% -36.55% -6.44% -25.72% 6.77% -23.96% -28.01% -27.3% -1.61% 10.73% 18.23% 21.39% 3.17% 23.87% 43.0% 10.61% -5.62% 4.81% -4.02% 10.8% 114.96% 2.48% 8.97% 24.46% 29.63% -4.54% 77.95% -47.01%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Interest Expense -$1.294B -$815.0M -$819.0M -$716.0M -$766.0M -$775.0M -$603.0M -$616.0M -$398.0M -$346.0M -$366.0M -$409.0M -$391.0M -$425.0M -$415.0M -$340.0M $47.00M $445.0M $165.0M $278.0M $91.00M $31.00M $113.0M -$11.00M -$11.00M -$60.00M -$16.00M -$20.00M -$30.00M -$58.00M -$132.0M -$267.0M -$293.0M
YoY Change 58.77% -0.49% 14.39% -6.53% -1.16% 28.52% -2.11% 54.77% 15.03% -5.46% -10.51% 4.6% -8.0% 2.41% 22.06% -823.4% -89.44% 169.7% -40.65% 205.49% 193.55% -72.57% -1127.27% 0.0% -81.67% 275.0% -20.0% -33.33% -48.28% -56.06% -50.56% -8.87%
% of Operating Profit -14.02% -21.57% -16.71% -16.28% -20.23% -31.84% -15.72% -15.02% -7.21% -6.69% -5.38% -4.33% -3.01% -3.22% -3.48% -3.37% 0.57% 5.53% 2.54% 6.11% 2.21% 0.71% 2.72% -0.25% -0.28% -3.3% -0.9% -1.23% -2.29% -5.75% -12.49% -44.95% -26.14%
Other Income/Expense, Net -$457.0M -$441.0M -$502.0M -$530.0M -$610.0M -$619.0M -$686.0M -$734.0M -$647.0M -$545.0M -$79.00M -$21.00M -$37.00M -$92.00M -$105.0M -$5.000M $34.00M $43.00M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.000M $13.00M -$86.00M -$301.0M $58.00M $26.00M $42.00M $108.0M
YoY Change 3.63% -12.15% -5.28% -13.11% -1.45% -9.77% -6.54% 13.45% 18.72% 589.87% 276.19% -43.24% -59.78% -12.38% 2000.0% -114.71% -20.93% -100.0% -76.92% -115.12% -71.43% -618.97% 123.08% -38.1% -61.11%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Pretax Income $6.899B $2.501B -$265.0M $3.916B $1.548B $1.993B $2.227B $3.552B $3.069B $1.246B $3.267B $7.718B $12.37B $10.98B $10.81B $8.681B $7.983B $8.543B $6.667B $4.825B $4.202B $4.037B $4.077B $3.847B $1.959B $1.732B $1.771B $1.521B $977.0M $1.009B $950.0M $179.0M $936.0M
YoY Change 175.85% -1043.77% -106.77% 152.97% -22.33% -10.51% -37.3% 15.74% 146.31% -61.86% -57.67% -37.59% 12.66% 1.57% 24.49% 8.74% -6.56% 28.14% 38.18% 14.83% 4.09% -0.98% 5.98% 96.38% 13.11% -2.2% 16.44% 55.68% -3.17% 6.21% 430.73% -80.88%
Income Tax $938.0M -$792.0M -$380.0M $772.0M $321.0M -$57.00M -$25.00M $146.0M $243.0M $11.00M $696.0M $1.391B $2.351B $2.896B $3.263B $2.551B $2.356B $2.480B $1.943B $1.155B $1.143B $1.177B $1.099B $1.299B $815.0M $547.0M $565.0M $499.0M $423.0M $321.0M $284.0M $18.00M $294.0M
% Of Pretax Income 13.6% -31.67% 19.71% 20.74% -2.86% -1.12% 4.11% 7.92% 0.88% 21.3% 18.02% 19.01% 26.38% 30.19% 29.39% 29.51% 29.03% 29.14% 23.94% 27.2% 29.16% 26.96% 33.77% 41.6% 31.58% 31.9% 32.81% 43.3% 31.81% 29.89% 10.06% 31.41%
Net Earnings $5.955B $3.293B $112.0M $3.196B $1.335B $2.155B $3.001B $3.499B $2.825B $1.233B $2.556B $6.297B $9.983B $8.053B $7.521B $6.101B $5.595B $6.043B $4.706B $3.651B $3.036B $2.836B $2.967B $2.538B $1.143B $1.183B $1.196B $1.003B $530.0M $678.0M $647.0M $140.0M $608.0M
YoY Change 80.84% 2840.18% -96.5% 139.4% -38.05% -28.19% -14.23% 23.86% 129.12% -51.76% -59.41% -36.92% 23.97% 7.07% 23.27% 9.04% -7.41% 28.41% 28.9% 20.26% 7.05% -4.42% 16.9% 122.05% -3.38% -1.09% 19.24% 89.25% -21.83% 4.79% 362.14% -76.97%
Net Earnings / Revenue 13.0% 7.42% 0.3% 12.01% 5.47% 9.76% 13.36% 15.21% 11.43% 4.64% 9.94% 22.51% 29.72% 24.21% 22.93% 19.31% 18.93% 22.83% 19.65% 17.04% 16.11% 15.9% 18.0% 14.02% 6.2% 12.96% 14.05% 11.98% 6.86% 9.89% 9.71% 2.01% 8.78%
Basic Earnings Per Share
Diluted Earnings Per Share $3.81 $2.11 $78.49K $2.434M $1.026M $1.701M $2.369M $2.764M $2.233M $975.5K $2.038M $4.982M $7.303M $5.569M $5.187M $4.199M $3.735M $3.849M $2.909M $2.180M $1.773M $1.635M $1.685M $1.434M $642.5K $1.240M $1.258M $1.056M $560.3K $716.7K $771.2K $194.4K $844.4K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Cash & Short-Term Investments $5.962B $6.405B $6.398B $7.992B $6.218B $5.680B $4.554B $5.902B $6.853B $7.155B $10.01B $8.524B $11.82B $12.55B $11.40B $4.674B $6.044B $7.760B $6.603B $5.234B $3.951B $4.688B $3.823B $4.450B $3.288B $614.0M $1.201B $1.669B $1.228B $1.151B $1.549B $631.0M
YoY Change -6.92% 0.11% -19.94% 28.53% 9.47% 24.73% -22.84% -13.88% -4.22% -28.54% 17.47% -27.88% -5.82% 10.07% 143.95% -22.67% -22.11% 17.52% 26.16% 32.47% -15.72% 22.63% -14.09% 35.34% 435.5% -48.88% -28.04% 35.91% 6.69% -25.69% 145.48%
Cash & Equivalents $4.515B $4.755B $4.868B $6.650B $4.614B $3.938B $2.540B $4.236B $4.990B $5.351B $8.123B $6.397B $6.083B $9.318B $8.841B $3.247B $4.464B $6.419B $4.434B $5.234B $253.0M $858.0M $1.350B $464.0M
Short-Term Investments $122.0M $239.0M $69.00M $160.0M $849.0M $849.0M $1.230B $884.0M $613.0M $795.0M $796.0M $823.0M $4.248B $1.482B $1.484B $388.0M $177.0M $657.0M $1.624B $3.218B $3.962B $3.118B $3.429B $2.859B $273.0M $702.0M $1.226B $975.0M $293.0M $199.0M $168.0M
Other Short-Term Assets $1.733B $1.566B $2.068B $1.877B $971.0M $2.676B $1.286B $1.025B $1.420B $1.419B $1.611B $1.129B $912.0M $938.0M $754.0M $681.0M $695.0M $767.0M $644.0M $2.217B $1.526B $576.0M $753.0M $832.0M
YoY Change 10.66% -24.27% 10.18% 93.31% -63.71% 108.09% 25.46% -27.82% 0.07% -11.92% 42.69% 23.79% -2.77% 24.4% 10.72% -2.01% -9.39% 19.1% 45.28% 164.93% -23.51% -9.5%
Inventory $5.424B $4.699B $8.983B $4.024B $3.193B $2.890B $3.035B $2.334B $2.143B $1.960B $1.909B $2.061B $1.852B $1.682B $1.750B $1.636B $2.119B $2.250B $2.206B $3.020B $3.022B $2.593B $2.402B $2.105B $2.156B $1.320B $1.199B $1.166B $1.319B $1.215B $1.146B $1.262B
Prepaid Expenses
Receivables $8.859B $7.508B $6.324B $3.956B $3.813B $2.995B $2.802B $2.583B $4.633B $4.762B $5.514B $5.696B $6.630B $6.247B $5.782B $5.558B $5.326B $4.288B $3.764B $4.771B $3.203B $2.645B $2.388B $2.663B $2.908B $2.514B $2.304B $2.361B $2.333B $2.189B $2.191B $1.863B
Other Receivables $3.076B $2.415B $2.471B $1.695B $1.368B $1.350B $1.473B $1.418B $958.0M $1.401B $1.288B $1.638B $2.293B $3.714B $4.072B $3.603B $2.898B $1.871B $553.0M $0.00 $540.0M $674.0M $664.0M $544.0M $730.0M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $25.05B $22.59B $26.24B $19.54B $15.56B $15.59B $13.15B $13.26B $16.01B $16.70B $20.34B $19.05B $23.51B $25.13B $23.76B $16.15B $17.08B $16.94B $13.77B $13.03B $12.93B $12.13B $9.853B $10.52B $9.914B $4.447B $4.704B $5.196B $4.879B $4.555B $4.886B $3.757B
YoY Change 10.89% -13.91% 34.28% 25.58% -0.18% 18.56% -0.84% -17.15% -4.13% -17.89% 6.76% -18.97% -6.47% 5.77% 47.1% -5.44% 0.86% 22.99% 5.72% 0.71% 6.66% 23.07% -6.3% 6.06% 122.94% -5.46% -9.47% 6.5% 7.11% -6.77% 30.05%
Property, Plant & Equipment $10.50B $9.449B $10.17B $8.917B $8.335B $7.421B $7.615B $6.848B $6.413B $6.010B $5.818B $6.089B $6.425B $6.957B $7.307B $7.043B $8.298B $7.453B $6.985B $8.097B $7.536B $6.597B $5.409B $4.957B $5.981B $3.624B $3.213B $3.119B $2.925B $2.714B $2.486B $2.354B
YoY Change 11.14% -7.1% 14.06% 6.98% 12.32% -2.55% 11.2% 6.78% 6.71% 3.3% -4.45% -5.23% -7.65% -4.79% 3.75% -15.12% 11.34% 6.7% -13.73% 7.44% 14.23% 21.96% 9.12% -17.12% 65.04% 12.79% 3.01% 6.63% 7.77% 9.17% 5.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.677B $1.142B $1.237B $1.147B $1.459B $922.0M $1.036B $826.0M $543.0M $561.0M $281.0M $199.0M $201.0M $211.0M $184.0M $156.0M $182.0M $119.0M $256.0M $262.0M $220.0M $46.00M $23.00M $11.00M $185.0M $241.0M $201.0M $202.0M $62.00M $61.00M $38.00M $50.00M
YoY Change 46.85% -7.68% 7.85% -21.38% 58.24% -11.0% 25.42% 52.12% -3.21% 99.64% 41.21% -1.0% -4.74% 14.67% 17.95% -14.29% 52.94% -53.52% -2.29% 19.09% 378.26% 100.0% 109.09% -94.05% -23.24% 19.9% -0.5% 225.81% 1.64% 60.53% -24.0%
Other Assets $5.220B $3.580B $4.823B $4.004B $3.171B $2.536B $2.693B $1.445B $1.740B $1.684B $1.570B $1.500B $1.856B $1.799B $1.554B $1.236B $1.044B $1.220B $1.117B $1.594B
YoY Change 45.81% -25.77% 20.45% 26.27% 25.04% -5.83% 86.37% -16.95% 3.33% 7.26% 4.67% -19.18% 3.17% 15.77% 25.73% 18.39% -14.43% 9.22% -29.92%
Total Long-Term Assets $76.07B $73.89B $79.12B $47.19B $45.81B $45.06B $50.20B $49.26B $44.05B $41.90B $35.56B $34.49B $29.32B $31.00B $31.16B $30.63B $30.88B $13.00B $11.07B $13.00B $10.64B $9.450B $8.132B $7.919B $9.902B $4.501B $3.548B $3.364B $3.015B $2.775B $2.525B $2.404B
YoY Change 2.94% -6.61% 67.68% 2.99% 1.67% -10.25% 1.91% 11.84% 5.13% 17.81% 3.13% 17.6% -5.39% -0.53% 1.72% -0.79% 137.57% 17.4% -14.87% 22.21% 12.59% 16.21% 2.69% -20.03% 120.0% 26.86% 5.47% 11.58% 8.65% 9.9% 5.03%
Total Assets $101.1B $96.48B $105.4B $66.73B $61.38B $60.65B $63.35B $62.53B $60.06B $58.60B $55.90B $53.53B $52.83B $56.13B $54.92B $46.78B $47.96B $29.93B $24.84B $26.03B $23.57B $21.58B $17.99B $18.43B $19.82B $8.948B $8.252B $8.560B $7.894B $7.330B $7.411B $6.161B
YoY Change
Accounts Payable $3.267B $2.550B $2.824B $2.350B $1.774B $1.720B $3.611B $2.990B $3.469B $3.492B $5.352B $4.935B $5.440B $5.096B $4.934B $3.903B $3.497B $3.482B $3.161B $3.086B $3.171B $2.385B $3.003B $1.614B $972.0M $871.0M $2.012B $2.091B $2.036B $1.974B $1.752B
YoY Change 28.12% -9.7% 20.17% 32.47% 3.14% -52.37% 20.77% -13.81% -0.66% -34.75% 8.45% -9.28% 6.75% 3.28% 26.42% 11.61% 0.43% 10.16% -2.68% 32.96% -20.58% 86.06% 66.05% 11.6% -56.71% -3.78% 2.7% 3.14% 12.67%
Accrued Expenses $8.861B $8.303B $8.079B $4.994B $5.085B $5.148B $3.794B $3.095B $3.190B $3.432B $3.813B $3.431B $2.817B $2.620B $2.715B $2.249B $2.606B $1.647B $1.117B $1.244B $1.022B $717.0M $827.0M $1.799B $425.0M $369.0M $0.00 $0.00 $0.00 $0.00 $1.844B
YoY Change 6.72% 2.77% 61.77% -1.79% -1.22% 35.69% 22.58% -2.98% -7.05% -9.99% 11.13% 21.8% 7.52% -3.5% 20.72% -13.7% 58.23% 47.45% 21.72% 42.54% -13.3% -54.03% 323.29% 15.18% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $515.0M $261.0M $294.0M $370.0M $154.0M $160.0M $152.0M $94.00M $189.0M $196.0M $222.0M $105.0M $137.0M $87.00M $90.00M $163.0M $140.0M $114.0M $84.00M $142.0M $152.0M $202.0M $214.0M $126.0M $344.0M $243.0M $273.0M $368.0M $374.0M $326.0M $149.0M $225.0M
YoY Change 97.32% -11.22% -20.54% 140.26% -3.75% 5.26% 61.7% -50.26% -3.57% -11.71% 111.43% -23.36% 57.47% -3.33% -44.79% 16.43% 22.81% 35.71% -40.85% -6.58% -24.75% -5.61% 69.84% -63.37% 41.56% -10.99% -25.82% -1.6% 14.72% 118.79% -33.78%
Long-Term Debt Due $4.885B $5.281B $1.599B $2.016B $1.856B $1.594B $2.095B $2.213B $727.0M $2.250B $1.566B $796.0M $1.853B $38.00M $1.836B $830.0M $4.140B $22.00M $6.000M $0.00 $314.0M $107.0M $88.00M $35.00M $35.00M $35.00M $21.00M $39.00M $19.00M $856.0M $17.00M
YoY Change -7.5% 230.27% -20.68% 8.62% 16.44% -23.91% -5.33% 204.4% -67.69% 43.68% 96.73% -57.04% 4776.32% -97.93% 121.2% -79.95% 18718.18% 266.67% -100.0% 193.46% 21.59% 151.43% 0.0% 0.0% 66.67% -46.15% 105.26% -97.78% 4935.29%
Total Short-Term Liabilities $30.54B $26.29B $22.59B $20.31B $18.12B $16.29B $16.38B $15.26B $14.87B $17.33B $16.05B $13.90B $15.75B $16.79B $17.64B $13.32B $15.19B $9.447B $6.839B $6.587B $7.695B $8.215B $6.480B $6.897B $7.019B $3.313B $3.068B $3.201B $3.137B $2.969B $3.485B $3.952B
YoY Change 16.16% 16.37% 11.26% 12.09% 11.2% -0.56% 7.39% 2.6% -14.2% 7.97% 15.45% -11.74% -6.17% -4.84% 32.43% -12.29% 60.76% 38.13% 3.83% -14.4% -6.33% 26.77% -6.05% -1.74% 111.86% 7.99% -4.15% 2.04% 5.66% -14.81% -11.82%
Long-Term Debt $23.22B $23.69B $28.89B $17.99B $16.22B $17.36B $15.56B $14.50B $14.14B $8.397B $8.588B $9.409B $7.338B $9.097B $9.137B $10.86B $10.88B $1.087B $1.111B $1.098B $355.0M $362.0M $787.0M $927.0M $1.202B $761.0M $860.0M $815.0M $831.0M $814.0M $821.0M $54.00M
YoY Change -1.98% -17.99% 60.54% 10.96% -6.58% 11.56% 7.3% 2.57% 68.36% -2.22% -8.73% 28.22% -19.34% -0.44% -15.83% -0.19% 900.55% -2.16% 1.18% 209.3% -1.93% -54.0% -15.1% -22.88% 57.95% -11.51% 5.52% -1.93% 2.09% -0.85% 1420.37%
Other Long-Term Liabilities $5.345B $6.498B $8.388B $9.872B $9.957B $9.670B $10.77B $12.14B $9.876B $11.43B $5.180B $3.694B $3.533B $3.688B $4.075B $3.423B $2.860B $2.423B $2.087B $1.847B $676.0M $563.0M $896.0M $1.068B $1.253B $663.0M $713.0M $883.0M $880.0M $817.0M $785.0M $1.986B
YoY Change -17.74% -22.53% -15.03% -0.85% 2.97% -10.25% -11.28% 22.96% -13.57% 120.58% 40.23% 4.56% -4.2% -9.5% 19.05% 19.69% 18.04% 16.1% 12.99% 173.22% 20.07% -37.17% -16.1% -14.76% 88.99% -7.01% -19.25% 0.34% 7.71% 4.08% -60.47%
Total Long-Term Liabilities $28.57B $30.19B $37.28B $27.87B $26.17B $27.03B $26.33B $26.65B $24.01B $19.82B $13.77B $13.10B $10.87B $12.79B $13.21B $14.28B $13.74B $3.510B $3.198B $2.945B $1.031B $925.0M $1.683B $1.995B $2.455B $1.424B $1.573B $1.698B $1.711B $1.631B $1.606B $2.040B
YoY Change -5.37% -19.01% 33.77% 6.46% -3.16% 2.64% -1.17% 10.96% 21.14% 43.98% 5.08% 20.53% -14.97% -3.23% -7.47% 3.95% 291.34% 9.76% 8.59% 185.65% 11.46% -45.04% -15.64% -18.74% 72.4% -9.47% -7.36% -0.76% 4.9% 1.56% -21.27%
Total Liabilities $61.98B $59.45B $66.10B $51.11B $48.25B $48.18B $48.39B $47.67B $41.57B $38.97B $32.68B $29.80B $29.58B $32.91B $34.26B $30.87B $33.18B $14.63B $11.24B $11.60B $10.40B $10.40B $8.199B $8.913B $9.514B $4.790B $4.694B $4.900B $4.848B $4.601B $5.091B $5.992B
YoY Change 4.26% -10.06% 29.33% 5.92% 0.14% -0.44% 1.51% 14.69% 6.67% 19.26% 9.66% 0.72% -10.12% -3.93% 10.97% -6.95% 126.82% 30.11% -3.1% 11.62% -0.09% 26.89% -8.01% -6.32% 98.62% 2.05% -4.2% 1.07% 5.37% -9.62% -15.04%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $196.11 Billion

About ASTRAZENECA PLC

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus. Its oncology candidate includes FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer, which is in a Phase II trial. The company also discovers, develops, and manufactures T-cell receptor therapies. Its Eneboparatide is an investigational therapeutic peptide.

Industry: Pharmaceutical Preparations Peers: Verona Pharma plc